We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Toprol-XL Competitors Hampered by Production Issues
Toprol-XL Competitors Hampered by Production Issues
January 29, 2009
AstraZeneca is the only drug company manufacturing its former blockbuster hypertension treatment Toprol-XL because compliance issues related to good manufacturing practices (GMP) have hindered generic competitors.